Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Single Nucleotide Polymorphism 96%
3. Genes 63%
4. Genome-Wide Association Study 54%
5. Pharmacogenetics 54%
6. Triple Negative Breast Neoplasms 53%
7. Cell Line 46%
8. Anastrozole 45%
9. Aromatase Inhibitors 43%
10. Neoplasms 39%
11. Gene Expression 38%
12. Drug Therapy 32%
13. RNA-Seq 31%
14. Genome 28%
15. Biomarkers 27%
16. Nucleotides 27%
17. gemcitabine 26%
18. Fuchs' Endothelial Dystrophy 26%
19. Genomics 25%
20. Estrogen Receptors 25%
21. Heterografts 24%
22. Exome 23%
23. Pharmaceutical Preparations 23%
24. Transcriptome 22%
25. High-Throughput Nucleotide Sequencing 22%
26. Trinucleotide Repeat Expansion 21%
27. Estrogens 20%
28. Cytidine 20%
29. exemestane 20%
30. RNA Sequence Analysis 20%
31. DNA 18%
32. Workflow 17%
33. Aryl Hydrocarbon Receptors 16%
34. Machine Learning 16%
35. Corneal Endothelium 16%
36. Genotype 16%
37. Datasets 15%
38. Irritable Bowel Syndrome 14%
39. RNA 14%
40. Prostatic Neoplasms 14%
41. Long Noncoding RNA 14%
42. Therapeutics 13%
43. Metformin 13%
44. Pharmacogenomic Testing 13%
45. Genetic Variation 13%
46. Computational Biology 13%
47. Transcription Factor 4 12%
48. Proteins 12%
49. Messenger RNA 12%
50. Genetic Polymorphisms 12%